Why Effective Participation Support Strategy is Critical to Trial Efficiency and Success in Rare Diseases
Trial participation exposes individuals to pressures that may become hurdles on the way to completing the study. This whitepaper from PRA’s Center for Rare Diseases addresses the challenges of understanding participation support and the methods used by PRA to overcome these barriers.
Strategies and Collaborations to Accelerate Rare Disease Clinical Development
Understanding the disease landscape and the competitive clinical trial environment when positioning a new clinical trial within the rare disease…
Uplifting Athletes: Helping the Rare Disease Community
The Patient Voice: Engaging Rare Disease Patients Improves Clinical Trial Enrollment & Retention
Clinical trials in rare diseases are complex and present unique challenges. However, patients in these trials are very vocal, with caretakers, family…